Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex.
about
Altered morphology of hippocampal dentate granule cell presynaptic and postsynaptic terminals following conditional deletion of TrkBBrain-derived neurotrophic factorChronic enhancement of CREB activity in the hippocampus interferes with the retrieval of spatial informationEntorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age.Interaction does Count: A Cross-Fostering Study on Transgenerational Effects of Pre-reproductive Maternal Enrichment.Adult Deletion of SRF Increases Epileptogenesis and Decreases Activity-Induced Gene Expression.BDNF-triggered events in the rat hippocampus are required for both short- and long-term memory formationNeural (N-) cadherin, a synaptic adhesion molecule, is induced in hippocampal mossy fiber axonal sprouts by seizureBrain-derived neurotrophic factor enhances the basal rate of protein synthesis by increasing active eukaryotic elongation factor 2 levels and promoting translation elongation in cortical neuronsWorking memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice.Disruption of TrkB-mediated phospholipase Cgamma signaling inhibits limbic epileptogenesisBrain-derived neurotrophic factor and epilepsy--a missing link?Brain-derived neurotrophic factor and the development of structural neuronal connectivity.A simple role for BDNF in learning and memory?Hippocampal excitability increases during the estrous cycle in the rat: a potential role for brain-derived neurotrophic factor.Localization of brain-derived neurotrophic factor to distinct terminals of mossy fiber axons implies regulation of both excitation and feedforward inhibition of CA3 pyramidal cellsBDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 miceRole of neurotrophins on postnatal neurogenesis in the thalamus: prenatal exposure to ethanol.Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learningTransgenic brain-derived neurotrophic factor modulates a developing cerebellar inhibitory synapse.Mutation of Elfn1 in mice causes seizures and hyperactivity.Expansion of the dentate mossy fiber-CA3 projection in the brain-derived neurotrophic factor-enriched mouse hippocampus.Adolescent mouse takes on an active transcriptomic expression during postnatal cerebral developmentConditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction.Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.Curcumin Improves Amyloid β-Peptide (1-42) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway.Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's diseaseAging-induced Seizure-related Changes to the Hippocampal Mossy Fiber Pathway in Forebrain Specific BDNF Overexpressing MiceNeurogenetic dissection of conditioned behavior: evolution by analogy or homology?Brain-derived neurotrophic factor as a drug target for CNS disorders.To BDNF or not to BDNF: that is the epileptic hippocampus.RNA aptamer-based functional ligands of the neurotrophin receptor, TrkBShedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.Conditional deletion of TrkC does not modify limbic epileptogenesisChanges in hippocampal function of ovariectomized rats after sequential low doses of estradiol to simulate the preovulatory estrogen surge.miRNA-132: a dynamic regulator of cognitive capacityThe cellular and synaptic location of activated TrkB in mouse hippocampus during limbic epileptogenesis.Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells.Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?
P2860
Q24602513-C54F60B0-257A-43D0-ACEB-96D2EC3125D2Q24647026-C8D05D59-D2F8-4225-A528-6603D85DFFC6Q24652490-E09E8BAE-3127-4CC2-9657-AABD227D7A4AQ27307826-5BE19061-8FB2-413E-AA29-27D2A7E0B2F7Q27322375-8BA8763D-49E4-4FEC-960F-9C6D281DA444Q27345329-13F66D57-2E17-46A2-B28C-47808A2BBED8Q28564618-4C30AE88-006E-48E5-BB82-C468CC131ABCQ28565660-AA9BB295-74F4-408D-9AD2-E3F41AA852F2Q28583609-FA595707-8BF5-4A03-B1D0-A2D315E0DCBAQ30465290-67BD4998-62B2-4076-91A3-28949EC4F971Q33861822-BFD30D06-D78B-4C38-B0B3-61D167D85778Q33941260-FBD6A2FF-79CF-4AA9-9E24-55E2BAAB3C92Q33946881-1F213169-4348-42FA-851A-FB8809E3B6F2Q34099252-A97EFE12-A293-4CC1-8ED6-3DD2BFB84EB2Q34131457-81726DE5-BB3F-45F6-824B-A978F2EE1A91Q34314205-6244374F-5B8C-42EC-A818-1E2580853C78Q34338809-8861BB23-6D11-47CE-A516-E977CD513D5FQ34687531-7F694FC1-E447-49FC-996D-0796CED197C6Q34743434-8B5F0CDA-34F3-4B4C-B946-C6B56F08AB37Q34931098-82887809-3E55-4A54-8DD0-D2FE622B20E1Q35039474-0627DD9A-AEF7-4E82-AE20-EA5279F75EFEQ35060316-85A1B341-EB19-40F3-AA3B-E454F88FC42DQ35073511-32D3B07B-06DC-4601-9109-56CB43F94B1BQ35192943-06DF6321-7D28-4008-BDB5-8F2BBB2EAE67Q35487248-E0E70CF1-679E-41AD-9CFB-CCC1171A7676Q35603915-2DF9E1F4-3E55-4CAE-A982-91CE87984595Q35675578-15DCD429-473F-492C-A58A-E82E880E4679Q35675598-44938698-402D-4366-9387-15D388E4C400Q35806798-65E33BB2-278D-4AD1-BF5E-436FBE97EF5FQ35809380-DB7777E7-6DD0-4351-846B-299FC5DC3ECDQ35911108-929D79B7-1C4A-46BD-BCB4-0C51621CA065Q36215206-D4137BCC-825C-49A5-A7ED-AF716CF44662Q36294425-6916CB0D-79AE-47E9-8AFB-2F29D9E4B865Q36364388-3F9D1624-EB06-4AE7-AB6C-1935CD440FE7Q36374155-CB22AB04-8D9E-4C64-84CD-7BE1135DE0D9Q36426664-5B079535-2508-45B9-A036-FBAD2118F4ADQ36428643-AF5553D8-3D67-4CBF-B405-52ADCD8AD6F2Q36481045-4C6D92EC-BA6A-409F-ADF3-4F5181221951Q36519737-CC9DDAE2-2641-4DE9-A901-D0549EAE2020Q36709214-5880EA5A-8A14-4EE6-9AE5-1DB4F64FA973
P2860
Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Brain-derived neurotrophic fac ...... ocampus and entorhinal cortex.
@en
type
label
Brain-derived neurotrophic fac ...... ocampus and entorhinal cortex.
@en
prefLabel
Brain-derived neurotrophic fac ...... ocampus and entorhinal cortex.
@en
P2093
P2860
P1433
P1476
Brain-derived neurotrophic fac ...... pocampus and entorhinal cortex
@en
P2093
D L Compton
G D Yancopoulos
H E Scharfman
M V Simmons
R M Lindsay
S J Wiegand
P2860
P304
P356
10.1016/S0306-4522(99)00296-1
P407
P577
1999-01-01T00:00:00Z